APA (7th ed.) Citation

IB, M., S, R., R, H., & MP, G. (2020). Treatment Experience and Repeat Pregnancy Impact the Effectiveness of Non-Nucleoside Reverse Transcription Inhibitor-Highly Active Antiretroviral Therapy for the Prevention of Mother to Child Transmission of Human Immunodeficiency Virus. AIDS research and human retroviruses, 36(8), 681. https://doi.org/10.1089/AID.2019.0001

Chicago Style (17th ed.) Citation

IB, Martin, Read S, Harrigan R, and Gomez MP. "Treatment Experience and Repeat Pregnancy Impact the Effectiveness of Non-Nucleoside Reverse Transcription Inhibitor-Highly Active Antiretroviral Therapy for the Prevention of Mother to Child Transmission of Human Immunodeficiency Virus." AIDS Research and Human Retroviruses 36, no. 8 (2020): 681. https://doi.org/10.1089/AID.2019.0001.

MLA (9th ed.) Citation

IB, Martin, et al. "Treatment Experience and Repeat Pregnancy Impact the Effectiveness of Non-Nucleoside Reverse Transcription Inhibitor-Highly Active Antiretroviral Therapy for the Prevention of Mother to Child Transmission of Human Immunodeficiency Virus." AIDS Research and Human Retroviruses, vol. 36, no. 8, 2020, p. 681, https://doi.org/10.1089/AID.2019.0001.